Article Details

Xbrane Biopharma releases interim report for January – September 2022 - MarketScreener

Retrieved on: 2022-10-28 18:09:40

Tags for this article:

Click the tags to see associated articles and topics

Xbrane Biopharma releases interim report for January – September 2022 - MarketScreener. View article details on hiswai:

Excerpt

Positive opinion from CHMP* paves the way for launch of Ximluci®. Xbrane Biopharma AB's (publ.) (”Xbrane”) interim report for January – September ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up